Navigation Links
Pneumonia Effectively Treated with Short-Term Antibiotic Course

Recent research has revealed that taking antibiotics for three days rather than the usual concept of seven to 10 days is equally effective in the treatment of common pneumonia // .

According to researchers this could also help to curb the rising problem of antibiotic-resistant bacteria,

Lead researcher Dr. Jan M Prins, an internist in infectious diseases at the Academic Medical Center, in Amsterdam said,’The question is how long you should treat common pneumonia. It turns out that three days is sufficient in children, and we now find the same in adults.’

The research team compared the effectiveness of three days of amoxicillin treatment with eight days of treatment in adults in cases of mild to moderate-severe pneumonia.

119 patients who had improved after three days of treatment with intravenous amoxicillin, and then assigned oral amoxicillin or a placebo for five days were taken as the subjects of the study.v It was found that 93 percent of the patients treated for three day or eight days, got better. Prins said, ‘For patients who responded after three days of antibiotic treatment, you could stop antibiotics and the results were comparable for those treated for eight days.’

The advantage lay in the fact that patients do not have to take in more medication than necessary. ‘In addition, there is a relation between how many antibiotics are used in a community and the rate of resistance among bacteria,’ he said. ‘If you can reduce the use of antibiotics, you can reduce the rate of resistance.’

The results of the research have been published in the June 10 issue of the British Medical Journal.

However Prins has cautioned that all diseases treated with antibiotics cannot become candidates for short-course treatment.

According to Dr. John Paul, from the Royal Sussex County Hospital, in England, and author of an accompanying editorial in the journal, ‘There is a lack of clear evidence to allow clinicians to know the optimal duration of antibiotic therapy for many common infections. He added, ‘We know that some infections do require long-term therapy to prevent relapse. We know for others that short courses of antibiotics are as good as long courses.’

‘This concept is smart,’ said Philip Tierno Jr., director of clinical microbiology and immunology at New York University Medical Center. ‘It eliminates three big problems: The cost to individuals of some of these newer antibiotics, adverse reactions and complications, and the development of resistanc.’


'"/>




Related medicine news :

1. Toxin connected to Flesh-eating Pneumonia in Kids
2. A new Vaccine for Pneumonia
3. The After Effects Of Pneumonia
4. Acid Suppressive Drugs Found To Increase The Risk for Pneumonia
5. Tsunami Survivors Face Pneumonia Threat
6. New Vaccine Found To Be Effective In Reducing Childhood Pneumonia
7. Zinc Effective In Helping Kids Recover From Pneumonia
8. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
9. Pneumonia Claims 30 Lives In Pakistan
10. Pneumonia Vaccine Effective Among Children
11. Five Tribal Children Succumbs to Pneumonia in Orissa
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... ... Today, the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 ... in 2017. Clinicians who participate in APMs are paid for the quality of care ... effort to build a system that delivers better care and one in which clinicians ...
(Date:1/19/2017)... ... ... Next week after January 20th, the fear for many is that the ... needs of over 30 million. Many interviews with Dr. Carol Francis at the Los ... were suppose to prioritize. Interviews provided below. , Among those present was ...
(Date:1/19/2017)... ... January 19, 2017 , ... With the cold weather here, many people will have to clear ... when clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s ... Safety Commission for the proper use of snow blowers:, , When ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... engineers, and scientists from around the world, announces the launch of its newly ... and easy portal to research breakthroughs and trending news, vital information on upcoming ...
(Date:1/19/2017)... Melville, New York (PRWEB) , ... January 19, ... ... state–of-the-art high definition dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with ... this newly designed product is an extension to RMT technology that delivers HD, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: